title: Major depressive disorder treatment guidelines in China.
abstract: Depression is a common illness in the Chinese population, but very few people with depression seek treatment or are properly diagnosed and treated when they do visit a medical professional. One potential result of this situation is that suicidality is higher than it might be if more people with depression received appropriate treatment. When patients do receive pharmacotherapy for depression, benzodiazepines and tricyclic antidepressants are overprescribed. The Chinese psychiatric establishment has published a sufficient guideline outlining treatment strategies for depressive disorders, but education for psychiatrists and general practitioners is needed.
authors.affiliation: Shanghai Jiaotong University, Shanghai Mental Health Center, Shanghai, China. myzhang2006@gmail.com
authors.forename: Mingyuan
authors.initials: M
authors.lastname: Zhang
mesh_terms: D000465:Algorithms; D000928:Antidepressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001569:Benzodiazepines / Q000627:therapeutic use; D002681:China; D003431:Cross-Cultural Comparison; D003430:Cross-Sectional Studies; D003865:Major Depressive Disorder / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology / Q000523:psychology; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D019317:Evidence-Based Medicine; D006760:Hospitalization; D006801:Humans; D008134:Long-Term Care; D017410:Practice Guidelines as Topic; D055502:Secondary Prevention
chemical_list: D000928:Antidepressive Agents; D001569:Benzodiazepines